Literature DB >> 22149168

Expression levels of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and focal adhesion kinase in patients with multiple myeloma and their relationship to clinical stage and extramedullary infiltration.

Su-Yun Wang1, Hong-Ling Hao, Kai Deng, Yan Li, Zhi-Yong Cheng, Chao Lv, Zhi-Miao Liu, Jie Yang, Ling Pan.   

Abstract

We explored the expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and focal adhesion kinase (FAK) mRNA and protein, and analyzed the relationship between expression levels and clinical staging and extramedullary infiltration in patients with multiple myeloma (MM). The expression levels of mRNA and protein were measured by fluorescence quantitative polymerase chain reaction (FQ-PCR) and Western blotting. Expressions of PTEN and FAK mRNA were significantly different between patients with MM and controls. Spearman bivariate correlation analysis showed that PTEN mRNA was significantly negatively correlated with FAK mRNA. PTEN and FAK mRNA expressions were significantly different between patients with stage I + II MM and stage III MM. No difference was found in PTEN mRNA expression, whereas FAK mRNA expression was significantly different between patients with MM with and without extramedullary infiltration. PTEN protein was higher and total FAK (T-FAK) protein was significantly lower in six controls than in 12 patients with stage III MM. Phosphorylated FAK (p-FAK) protein was measured as 0.082 ± 0.040 in 11 patients with MM, but not detected in six controls. No significant difference of PTEN and T-FAK protein was found, while p-FAK protein was significantly different between patients with MM with and without extramedullary infiltration. These results indicate that abnormal expression of PTEN and FAK in patients with MM may be associated with disease progression and extramedullary infiltration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22149168     DOI: 10.3109/10428194.2011.647311

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  11 in total

Review 1.  Extramedullary multiple myeloma.

Authors:  Manisha Bhutani; David M Foureau; Shebli Atrash; Peter M Voorhees; Saad Z Usmani
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

2.  PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242.

Authors:  Chunmei Yang; Xianbo Huang; Hui Liu; Feng Xiao; Jueying Wei; Liangshun You; Wenbin Qian
Journal:  Oncotarget       Date:  2017-06-13

Review 3.  New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway.

Authors:  Roberta Alfieri; Elisa Giovannetti; Mara Bonelli; Andrea Cavazzoni
Journal:  Front Oncol       Date:  2017-08-09       Impact factor: 6.244

4.  Clinical Characteristics and Prognostic Analysis of Multiple Myeloma with Extramedullary Disease: A SEER-Based Study.

Authors:  Guang Li; Yan-Ping Song; Yao Lv; Zhen-Zhen Li; Yan-Hua Zheng
Journal:  J Oncol       Date:  2021-01-30       Impact factor: 4.375

5.  Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeleton.

Authors:  S Mithraprabhu; T Khong; A Spencer
Journal:  Cell Death Dis       Date:  2014-03-20       Impact factor: 8.469

6.  Asiatic acid, a triterpene, inhibits cell proliferation through regulating the expression of focal adhesion kinase in multiple myeloma cells.

Authors:  Junli Zhang; Lisha Ai; Tingting Lv; Xudong Jiang; Fang Liu
Journal:  Oncol Lett       Date:  2013-10-01       Impact factor: 2.967

7.  Methylation analysis of the phosphates and tensin homologue on chromosome 10 gene (PTEN) in multiple myeloma.

Authors:  Giovanna Piras; Maria Monne; Angelo D Palmas; Anna Calvisi; Rosanna Asproni; Francesco Vacca; Laura Pilo; Attilio Gabbas; Giancarlo Latte
Journal:  Clin Epigenetics       Date:  2014-08-20       Impact factor: 6.551

8.  Phosphorylation of phosphatase and tensin homolog induced by Helicobacter pylori promotes cell invasion by activation of focal adhesion kinase.

Authors:  Zhen Yang; Ximei Cao; Wenting Xu; Chuan Xie; Jiang Chen; Yin Zhu; Nonghua Lu
Journal:  Oncol Lett       Date:  2017-11-16       Impact factor: 2.967

Review 9.  Kinase inhibitors as potential agents in the treatment of multiple myeloma.

Authors:  Hanley N Abramson
Journal:  Oncotarget       Date:  2016-12-06

Review 10.  Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.

Authors:  Rayan Naser; Abdullah Aldehaiman; Escarlet Díaz-Galicia; Stefan T Arold
Journal:  Cancers (Basel)       Date:  2018-06-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.